日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease

对一种原型 mTOT 调节胰岛素增敏剂 MSDC-0160 在轻度阿尔茨海默病患者中的评估

Shah, Raj C; Matthews, Dawn C; Andrews, Randolph D; Capuano, Ana W; Fleischman, Debra A; VanderLugt, James T; Colca, Jerry R

Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein

外周血单核细胞处理和生存运动神经元蛋白分析的评估

Dione T Kobayashi, Douglas Decker, Phillip Zaworski, Karen Klott, Julie McGonigal, Nabil Ghazal, Laurel Sly, Brett Chung, James Vanderlugt, Karen S Chen

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis

抗VLA-4治疗在复发性实验性自身免疫性脑脊髓炎发病前后的不一致效应

Theien, B E; Vanderlugt, C L; Eagar, T N; Nickerson-Nutter, C; Nazareno, R; Kuchroo, V K; Miller, S D

CTLA-4: a negative regulator of autoimmune disease

CTLA-4:自身免疫性疾病的负调控因子

Karandikar, N J; Vanderlugt, C L; Walunas, T L; Miller, S D; Bluestone, J A